ALG-000184, a capsid assembly modulator, dosed with entecavir for up to 28 weeks is well tolerated and resulted in substantial declines in surface antigen levels in untreated Hepatitis B e antigen positive subjects with chronic hepatitis B

Saved in:
Bibliographic Details
Published inJournal of hepatology Vol. 78; pp. S112 - S113
Main Authors Hou, Jinlin, Ding, Yanhua, Niu, Junqi, Liang, Xieer, Yuen, Man-Fung, Gane, Edward J., Agarwal, Kosh, Wu, Min, Le, Kha, Venkatraman, Meenakshi, Westland, Christopher, Maderazo, Maida, Chanda, Sushmita, Beigelman, Leonid, Blatt, Lawrence, Lin, Tse-I, McClure, Matt, Fry, John
Format Journal Article
LanguageEnglish
Published 01.06.2023
Online AccessGet full text

Cover

More Information
ISSN:0168-8278
DOI:10.1016/S0168-8278(23)00600-1